ASPM is aberrantly expressed in various tumors, such as glioblastoma (41), endometrial adenocarcinoma (42), pancreatic cancer (43), prostate adenocarcinoma (44), and ovarian cancer (45, 46), and is associated with tumor prognosis. This evidence concerns the gene ASPM and familial pancreatic carcinoma.